Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Marvel Biosciences Corp (MBCOF)

Marvel Biosciences Corp (MBCOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Marvel Biosciences Announces Grant of Deferred Share Units Newsfile - Mon Nov 10, 4:22PM CST

Calgary, Alberta--(Newsfile Corp. - November 10, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Acceleration of Warrant Expiry Date Newsfile - Fri Oct 3, 4:10AM CDT

Calgary, Alberta--(Newsfile Corp. - October 3, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is announcing...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204 Newsfile - Mon Aug 18, 4:14PM CDT

Calgary, Alberta--(Newsfile Corp. - August 18, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Grant of Deferred Share Units Newsfile - Mon Aug 11, 5:14PM CDT

Calgary, Alberta--(Newsfile Corp. - August 11, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Closing of Private Placement Newsfile - Mon May 12, 5:10PM CDT

Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Closing of Second Tranche of Private Placement Newsfile - Fri May 2, 6:14AM CDT

Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Announces the Second of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide Following Cessation of Drug Treatment Newsfile - Wed Apr 30, 6:14AM CDT

Calgary, Alberta--(Newsfile Corp. - April 30, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences to Give Oral Presentation at The Annual IRSF Rett Syndrome Scientific Meeting Newsfile - Wed Apr 16, 6:08AM CDT

Calgary, Alberta--(Newsfile Corp. - April 16, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (together "Marvel"), are pleased to...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Selected to Present Alzheimer's Research at the 2025 Alzheimer's Association International Conference Newsfile - Mon Apr 14, 6:10AM CDT

Calgary, Alberta--(Newsfile Corp. - April 14, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Private Placement Newsfile - Fri Mar 28, 3:30PM CDT

Calgary, Alberta--(Newsfile Corp. - March 28, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)

Barchart Exclusives

S&P Futures Tick Higher Ahead of FOMC Meeting and U.S. JOLTs Report Barchart - 44 minutes ago
December S&P 500 E-Mini futures (ESZ25) are trending up +0.07% this morning as investors gear up for the start of the Federal Reserve’s two-day policy meeting, while also awaiting the delayed reading on U.S. job openings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot